Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 134.60
-0.20 (-0.15%)
Jul 11, 2025, 2:58 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 2.24 billion as of July 11, 2025. Its market cap has increased by 22.57% in one year.
Market Cap
2.24B
Enterprise Value
2.18B
Revenue
221.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
134.60
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 2.24B, an increase of 65.47%. That is a compound annual growth rate of 15.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 2.24B | 14.33% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 97.40B |
| Sectra AB | 69.68B |
| Getinge AB | 52.40B |
| Asker Healthcare Group AB | 40.92B |
| Camurus AB | 39.75B |
| Medicover AB | 39.10B |
| AddLife AB | 22.48B |
| Vimian Group AB | 22.22B |